SCHEMBL25461532

SCHEMBL25461532

CCCC(C)n1nc(Br)c2cnc(Cl)cc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25461721 1.00 — —
SCHEMBL25461863 0.85 ADORA2A (0.33) —
SCHEMBL25167213 0.80 — —
SCHEMBL30142441 0.80 — —
SCHEMBL25167212 0.80 — —
SCHEMBL25461861 0.74 — —
SCHEMBL16374237 0.72 MAP4K1 (0.30) —
SCHEMBL16339681 0.72 MAP4K1 (0.30) —
SCHEMBL16374239 0.72 MAP4K1 (0.30) —
SCHEMBL25461759 0.72 ALDH1A1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230148005-A1 MACROCYCLIC COMPOUNDS AND USES THEREOF THESEUS PHARMACEUTICALS, INC. 2023-05-11 — — US disclosed
Send feedback